Innoviva (INVA) Liabilities and Shareholders Equity (2016 - 2025)
Innoviva (INVA) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $1.6 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 25.68% year-over-year to $1.6 billion, compared with a TTM value of $5.7 billion through Dec 2025, up 12.48%, and an annual FY2025 reading of $1.6 billion, up 25.68% over the prior year.
- Liabilities and Shareholders Equity was $1.6 billion for Q4 2025 at Innoviva, up from $1.4 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $1.6 billion in Q4 2025 and bottomed at $789.2 million in Q2 2021.
- Average Liabilities and Shareholders Equity over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2022.
- The sharpest move saw Liabilities and Shareholders Equity skyrocketed 49.65% in 2022, then fell 10.51% in 2023.
- Year by year, Liabilities and Shareholders Equity stood at $926.4 million in 2021, then soared by 32.93% to $1.2 billion in 2022, then grew by 0.98% to $1.2 billion in 2023, then grew by 4.63% to $1.3 billion in 2024, then increased by 25.68% to $1.6 billion in 2025.
- Business Quant data shows Liabilities and Shareholders Equity for INVA at $1.6 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.3 billion in Q2 2025.